Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma

[51] Radek EH(2017)Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer Oncoimmunology undefined undefined-undefined

[52] Choi I(2021)Development and validation of a gene mutation-associated nomogram for hepatocellular carcinoma patients from four countries Front Genet undefined undefined-undefined

[53] Shibahara R(2019)Integrated analysis of TP53 gene and pathway alterations in the cancer genome atlas Cell Rep undefined undefined-undefined

[54] Saito R(2017)Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features Gastroenterology. undefined undefined-undefined

[55] Zhang SC(2019)Beta-catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma Cancer Discov. undefined undefined-undefined

[56] Wei CR(2019)Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors Oncoimmunology undefined undefined-undefined

[57] Duffy JP(2021)Survival prediction and response to immune checkpoint inhibitors: a prognostic immune signature for hepatocellular carcinoma Transl Oncol undefined undefined-undefined

[58] Allison L(undefined)undefined undefined undefined undefined-undefined

[59] Aye X(undefined)undefined undefined undefined undefined-undefined

[60] Song J(undefined)undefined undefined undefined undefined-undefined

[51] Radek EH(2017)Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer Oncoimmunology undefined undefined-undefined

[52] Choi I(2021)Development and validation of a gene mutation-associated nomogram for hepatocellular carcinoma patients from four countries Front Genet undefined undefined-undefined

[53] Shibahara R(2019)Integrated analysis of TP53 gene and pathway alterations in the cancer genome atlas Cell Rep undefined undefined-undefined

[54] Saito R(2017)Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features Gastroenterology. undefined undefined-undefined

[55] Zhang SC(2019)Beta-catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma Cancer Discov. undefined undefined-undefined

[56] Wei CR(2019)Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors Oncoimmunology undefined undefined-undefined

[57] Duffy JP(2021)Survival prediction and response to immune checkpoint inhibitors: a prognostic immune signature for hepatocellular carcinoma Transl Oncol undefined undefined-undefined

[58] Allison L(undefined)undefined undefined undefined undefined-undefined

[59] Aye X(undefined)undefined undefined undefined undefined-undefined

[60] Song J(undefined)undefined undefined undefined undefined-undefined